Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κb pathway in rat liver

Diabetes

Volumn 54, Issue 12, 2005, Pages 3458-3465

  Boden, Guenther ^a,c   She, Pengxiang ^a   Mozzoli, Maria ^a   Cheung, Peter ^a   Gumireddy, Kiranmai ^a   Reddy, Prekumar ^a   Xiang, Xiaqin ^b   Luo, Zhijan ^b   Ruderman, Neil ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN SERINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENYLATE KINASE; ANIMALS; BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; I-KAPPA B PROTEINS; INSULIN; INSULIN RESISTANCE; KINETICS; LIVER; MALE; NF-KAPPA B; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 29044447292     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3458     Document Type: Article

References (40)

1. Mokdad AN, Bowman BA, Ford ES: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
2. Tataranni PA, Ortega E: A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54:917-927, 2005
3. Boden G: Free fatty acids as target for therapy. Curr Opin Endocrinol Diab 11:258-263, 2004
4. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
5. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of fatty acids on glucose transport and IRS-1 associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
6. Itani SI, Ruderman NB, Schmieder, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011, 2002
7. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353, 2004
8. Lam TKT, Yoshii H, Haber A, Bogdanovic Lam L, Fantus G, Giacca A: Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ. Am J Physiol 283:E682-E691, 2002
9. Mittleman SD, Van Citters GW, Kirkman EL, Bergman RN: Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51:755-761, 2002
10. Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R: A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord 18:219-234, 1994
11. Cheung P, Yang G, Boden G: Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion. Metabolism 52:1496-1500, 2003
12. Steele R, Wall JS, DeBodo RC, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
13. Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE, Bell RM: Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261:8597-8600, 1986
14. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang C, Itani SI, Lodish HF, Ruderman NB: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99:16309-16313, 2002
15. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231, 2002
16. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E: Rat proinflammatory cytokine and cytokine related mRNA quantitation by real-time polymerase chain reaction using SYBR Green. BMC Immunol 5:3-12, 2004
17. Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol 283:E12-E19, 2002
18. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
19. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236, 2002
20. Ruderman NB, Saha AK, Vavvas D, Witters LA: Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18, 1999
21. Bronfman M, Morales MN, Orellana A: Diacylglycerol activation of protein kinase C is modulated by long-chain acyl-CoA. Biochem Biophys Res Commun 152:987-992, 1988
22. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496, 1995
23. Turinsky J, Bayly BP, O'Sullivan DM: 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo: studies with insulin, exercise, muscle denervation, and vasopressin. J Biol Chem 265:7933-7938, 1990
24. Bell KS, Schmitz-Peiffer C, Lim-Fraser M, Biden TJ, Cooney GJ, Kraegen EW: Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. Am J Physiol Endocrinol Metab 279:E1196-E1201, 2001
25. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS: Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle: altered protein kinase C activity and possible link to insulin resistance. Diabetes 40:1707-1711, 1991
26. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945, 2000
27. Altman A, Isakov N, Baier G: Protein kinase C theta: a new essential superstar on the T-cell stage. Immunol Today 21:567-573, 2000
28. Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, Littman DR, Rawlings DJ, Kawakami T: Protein kinase C βII Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem 279:47720-47725, 2004
29. De Fea K, Roth RA: Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 36:12939-12947, 1997
30. Ravichandran V, Esposito DL, Chen J, Quon MJ: Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 276:3543-3549, 2001
31. 1010. J Biol Chem 279:45304-45307, 2004
32. Greene MW, Morrice N, Garofalo RS, Roth RA: Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cδ. Biochem J 378:105-116, 2004
33. Saha AK, Avilucea PR, Assifi MM, Kraegen EW, Ruderman NB: Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314:580-585, 2004
34. Karin M, Yamamoto Y, Wang QM: The IKK NFκB system: a treasure trove for drug development. Nat Rev 3:17-26, 2004
35. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
36. Browning JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152, 2004
37. Chomcznki P, Saacchi N: Single-step method of RNA isolation by acid guadinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
38. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11:183-190, 2005
39. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673-1677, 2001
40. Arkan MC, Hevener AL, Greten FR, Maeda S, Li Z-W, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198, 2005